Skip to content

The feasibility of using plastic cannula for haemodialysis treatments

Haemodialysis Plastic Cannulae for patients with end stage kidney disease: A Randomized Crossover Feasibility Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000341921
Enrollment
20
Registered
2020-03-11
Start date
2020-04-01
Completion date
2020-05-30
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Patients with kidney disease require 6 metal needles per week. The use of metal dialysis needles can lead to complications such as bruising, swelling and pain. The aim of this study is to measure feasibility related aspects of the introduction of plastic needles in haemodialysis clinics. Participants will receive metal needles and plastic needles and the study will compare needle complications and participant anxiety.

Interventions

Intervention will be the use of plastic cannulae to facilitate blood access for haemodialysis. Trained registered nurses with a minimum of 1 year experience will be inserting the plastic cannulae. These nurses already are trained in plastic cannulae insertion. Plastic cannulae will be used for a 12 week period, 3 times per week at every haemodialysis session. Participants will be randomized to 12 weeks of plastic cannulae followed by 12 weeks of metal needles (Group 1) or to 12 weeks of metal ne

Intervention will be the use of plastic cannulae to facilitate blood access for haemodialysis. Trained registered nurses with a minimum of 1 year experience will be inserting the plastic cannulae. These nurses already are trained in plastic cannulae insertion. Plastic cannulae will be used for a 12 week period, 3 times per week at every haemodialysis session. Participants will be randomized to 12 weeks of plastic cannulae followed by 12 weeks of metal needles (Group 1) or to 12 weeks of metal needles followed by 12 weeks of plastic cannulae (Group 2). There is no washout period as it is not feasible or ethical for patients to not have dialysis treatment (requiring needle or cannula insertion) in between arms. This will take place at renal dialysis units within Barwon Health.

Sponsors

Barwon Health
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Diagnosed with end stage kidney disease Receiving hemodialysis in a Barwon Health clinic. Receiving dialysis for a minimum of 6 weeks Using an arterio-venous fistula

Exclusion criteria

Cognitive impairment, Inability to understand English Home dialysis patients

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026